Cicada covid: new strain emerges – should you worry?
Another COVID variant is making headlines, and it’s easy to feel like we're back at square one. Dubbed ‘Cicada,’ this latest strain is prompting questions about potential risks and what we should be doing to protect ourselves. But before anxiety sets in, experts are urging calm, reminding us that viral evolution is a natural process.
Understanding the 'cicada' variant (ba.3.2)
The moniker 'Cicada' is a bit unusual, but it stems from the variant's lineage. As Lead Prescribing Pharmacist Ian Budd explains, it's technically designated BA.3.2 and belongs to the Omicron family. The name itself references its dormancy—a near four-year absence, much like the insect cicadas which lie dormant for extended periods before re-emerging.
What differentiates Cicada is the sheer number of mutations it carries, particularly within the region of the virus that helps it bind to our cells. This could potentially enhance its ability to spread and evade some of the immunity built from previous vaccinations or infections. However, and this is a crucial point, there’s currently no strong evidence indicating it causes more severe illness than recent variants.

Recognizing the symptoms: is it just another cold?
The symptoms associated with Cicada appear remarkably similar to those we’ve become accustomed to with other Omicron strains. Sore throats, coughs, fatigue, fevers, headaches, and congestion are all common indicators. But one detail has emerged in early reports: a notably painful sore throat seems to be a more prominent feature with this particular variant. While not entirely new, it's a symptom to monitor.
The key takeaway? Don't panic. The emergence of new variants is a persistent reality, and each iteration often results in minor adjustments to the virus’s behavior. The ongoing circulation of the virus, coupled with each replication event, creates opportunities for these small changes to accumulate.

What to do if you suspect infection
The landscape of pandemic response has dramatically shifted, thankfully. But a core principle remains: cautiousness. If you’re experiencing any of the aforementioned symptoms, a rapid lateral flow test is your first line of defense. The advice is straightforward: isolate if you feel unwell and avoid close contact with vulnerable individuals – those with compromised immune systems, the elderly, and young children. And, crucially, staying up-to-date with vaccinations continues to be one of the most effective ways to mitigate the risk of severe illness, even as the virus continues to evolve.
The emergence of Cicada serves as a reminder that COVID-19 is not a relic of the past. It’s an evolving entity that demands continued vigilance and adaptation. While the initial wave of fear may be tempting, a measured and informed response, grounded in sound public Health practices, remains our best course of action.